Published in Surgery on February 01, 1977
Mesenteric panniculitis: US and CT features. Eur Radiol (2004) 1.61
Occasional finding of mesenteric lipodystrophy during laparoscopy: a difficult diagnosis. World J Gastroenterol (2007) 1.42
An unusual presentation of sclerosing mesenteritis as pneumoperitoneum: case report with a review of the literature. World J Gastroenterol (2009) 1.17
Sclerosing Mesenteritis: Diverse clinical presentations and dissimilar treatment options. A case series and review of the literature. Int Arch Med (2011) 1.04
Successful management of symptoms of steroid-dependent mesenteric panniculitis with colchicine. Dig Dis Sci (2006) 1.03
Idiopathic sclerosing mesenteritis in paediatrics: Report of a successfully treated case and a review of literature. Pediatr Rheumatol Online J (2010) 0.99
Mesenteric panniculitis: prevalence, clinicoradiological presentation and 5-year follow-up. Br J Radiol (2014) 0.98
Mesenteric panniculitis. West J Med (1988) 0.96
Retractile mesenteritis presenting as protein-losing gastroenteropathy. Can J Gastroenterol (2006) 0.89
IgG4-related sclerosing mesenteritis in a 7-year-old Saudi girl. Saudi J Gastroenterol (2014) 0.88
Mesenteric lipodystrophy. J Clin Pathol (1993) 0.87
Extensive sclerosing mesenteritis of the rectosigmoid colon associated with erosive colitis. Gastroenterol Res Pract (2009) 0.86
Normal Positron Emission Tomography-Computerized Tomogram in a Patient with Apparent Mesenteric Panniculitis: Biopsy Is Still the Answer. Case Rep Gastroenterol (2009) 0.84
Sclerosing mesenteritis involving the pancreas: a mimicker of pancreatic cancer. Am J Surg Pathol (2010) 0.80
Benign mesenteric lipodystrophy presenting as low abdominal pain: a case report. J Med Case Rep (2010) 0.79
Mesenteric panniculitis: a case report and review of the literature. Maedica (Buchar) (2012) 0.78
Sclerosing mesenteritis as a cause of abdominal mass and discomfort in an elderly patient: a case report and literature review. Case Rep Med (2010) 0.77
Mesenteric Panniculitis in a Thirteen-Year-Old Korean Boy Treated with Prednisolone: A Case Report. Pediatr Gastroenterol Hepatol Nutr (2016) 0.75
Undiagnosed Sjögren's Syndrome Presenting as Mesenteric Panniculitis. Case Rep Rheumatol (2016) 0.75
An Interesting Case of Recurrent Small Bowel Obstruction. Case Rep Gastroenterol (2009) 0.75
Chronic abdominal pain secondary to mesenteric panniculitis treated successfully with endoscopic ultrasonography-guided celiac plexus block: A case report. World J Gastrointest Endosc (2015) 0.75
Mesenteric panniculitis. Postgrad Med J (1980) 0.75
Retractile mesenteritis appearing as a sigmoid colon tumor. Tech Coloproctol (2010) 0.75
A case of protein-losing enteropathy caused by sclerosing mesenteritis diagnosed with capsule endoscopy and double-balloon endoscopy. Clin J Gastroenterol (2017) 0.75
Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene (2006) 4.85
Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1. Nature (1983) 4.44
New human transforming genes detected by a tumorigenicity assay. Mol Cell Biol (1984) 3.43
ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor. Nat Cell Biol (2000) 2.90
BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene (1991) 2.89
Mutations of ASXL1 gene in myeloproliferative neoplasms. Leukemia (2009) 2.77
Histoprognostic grade in BRCA1-associated breast cancer. Lancet (1995) 2.47
Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis. J Pathol (1998) 2.40
A fronto-parietal circuit for object manipulation in man: evidence from an fMRI-study. Eur J Neurosci (1999) 2.33
WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene (2001) 2.32
Characterization of the HST-related FGF.6 gene, a new member of the fibroblast growth factor gene family. Oncogene (1989) 2.20
Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum Mol Genet (2000) 2.15
Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer (1995) 2.05
Surgical aspects of gastrointestinal persimmon phytobezoar treatment. Am J Surg (1986) 2.01
Characterization of an activated human ros gene. Mol Cell Biol (1986) 1.97
Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet (1999) 1.96
Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J Immunol (1989) 1.86
A refined molecular taxonomy of breast cancer. Oncogene (2011) 1.78
Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms. Leukemia (2010) 1.75
SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias. Leukemia (2013) 1.65
Collective nomenclature for LAP proteins. Nat Cell Biol (2000) 1.64
Ancient large-scale genome duplications: phylogenetic and linkage analyses shed light on chordate genome evolution. Mol Biol Evol (1998) 1.57
Of worms and men: an evolutionary perspective on the fibroblast growth factor (FGF) and FGF receptor families. J Mol Evol (1997) 1.51
Low serum C3, leukopenia, and thrombocytopenia: unusual features of henoch-schonlein purpura. Eur J Pediatr (1999) 1.50
Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma. Cytogenet Cell Genet (1997) 1.48
Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur J Immunol (2001) 1.46
Bilateral pulmonary artery aneurysms in Behçet's disease. Eur Respir J (1993) 1.45
Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias. Leukemia (2009) 1.45
Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family. Oncogene (1991) 1.44
Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles. Oncogene (2008) 1.44
Endobronchial actinomycosis simulating bronchogenic carcinoma. Diagnosis by bronchial biopsy. Chest (1991) 1.44
Basal breast cancer: a complex and deadly molecular subtype. Curr Mol Med (2012) 1.43
Expression of the Fgf6 gene is restricted to developing skeletal muscle in the mouse embryo. Development (1993) 1.41
Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples. Hum Mol Genet (1999) 1.39
Postpartum renal failure in systemic lupus erythematosus. Clin Nephrol (1990) 1.39
Mutations at BRCA1: the medullary breast carcinoma revisited. Cancer Res (1998) 1.39
Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes. Oncogene (1999) 1.39
Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia (1996) 1.38
Molecular analysis of the NPM-ALK rearrangement in Hodgkin's disease. J Pathol (1996) 1.38
Dual challenge for glomerular damage in mice: uninephrectomy and repetitive pregnancies. Isr J Med Sci (1990) 1.37
Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages. Blood (1992) 1.37
Serum CK, calcium, magnesium, and oxidative phosphorylation in mdx mouse muscular dystrophy. Muscle Nerve (1988) 1.36
Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res (1997) 1.33
Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. J Mol Endocrinol (2004) 1.33
Nephrotic syndrome associated with amyloid-like glomerular deposits. Nephron (1977) 1.33
Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood (1993) 1.32
The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene (1993) 1.32
Idiopathic infantile arterial calcification: a case report and review of the literature. Eur J Pediatr (1984) 1.32
Plasma amino acids as predictors of the severity and outcome of sepsis. Ann Surg (1979) 1.31
Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood (1997) 1.30
MOZ is fused to p300 in an acute monocytic leukemia with t(8;22). Genes Chromosomes Cancer (2000) 1.30
Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer. Cancer Res (2000) 1.29
Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chromosomes Cancer (1994) 1.27
Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogénétique hématologique. Leukemia (2008) 1.27
Submicrometer intracellular chemical optical fiber sensors. Science (1992) 1.26
Acute pancreatitis and hyperamylasemia in renal homograft recipients. Arch Surg (1972) 1.24
Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy. Oncogene (2006) 1.23
Murine FGF-12 and FGF-13: expression in embryonic nervous system, connective tissue and heart. Mech Dev (1997) 1.22
The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1. Blood (1999) 1.21
Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res (1996) 1.21
Structure and expression of human fibroblast growth factor-10. J Biol Chem (1997) 1.20
Handedness and asymmetry of hand representation in human motor cortex. J Neurophysiol (1998) 1.20
FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33). Blood (2000) 1.20
Influence of mood on health-relevant cognitions. J Pers Soc Psychol (1989) 1.19
Renal pathologic findings associated with monoclonal gammopathies. Arch Intern Med (1975) 1.19
Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy. Eur Respir J (2008) 1.17
Chromatin-positive Klinefelter's syndrome with undetectable peripheral FSH levels. Am J Med (1975) 1.16
Fibroblast growth factor gene expression in AIDS-Kaposi's sarcoma detected by in situ hybridization. Am J Pathol (1991) 1.16
Localization of the mcf.2 transforming sequence to the X chromosome. EMBO J (1987) 1.16
The ERBB2/HER2 receptor differentially interacts with ERBIN and PICK1 PSD-95/DLG/ZO-1 domain proteins. J Biol Chem (2001) 1.16
FLT3 signaling in hematopoietic cells involves CBL, SHC and an unknown P115 as prominent tyrosine-phosphorylated substrates. Leukemia (1998) 1.15
Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer. Oncogene (2006) 1.15
Fibroblast growth factor receptor-4 shows novel features in genomic structure, ligand binding and signal transduction. EMBO J (1992) 1.14
Homeobox gene clusters and the human paralogy map. FEBS Lett (2001) 1.13
Measuring in vivo myelination of human white matter fiber tracts with magnetization transfer MR. Neuroimage (1999) 1.12
Serum complement after orthotopic transplantation of the human liver. Clin Exp Immunol (1972) 1.12
Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas. Oncogene (1989) 1.12
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism. Br J Cancer (2009) 1.12
Expression of the FGFR1 gene in human breast-carcinoma cells. Int J Cancer (1994) 1.11
Myelodysplastic syndromes: lost between two states? Leukemia (2010) 1.11
Fatal late postpartum intravascular coagulation with acute renal failure. Am J Med Sci (1969) 1.10
Evidence for a third breast-cancer susceptibility gene. Lancet (1994) 1.09
Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene. Genomics (1992) 1.08
Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase. Oncogene (1995) 1.08
Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene (2006) 1.08
HLA cosmid clones show complete, widely spaced human class I genes with occasional clusters. Gene (1982) 1.07
p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results. Br J Cancer (1994) 1.07
Detection of Australia antigen by biological assay in 'Au negative' kidney homograft recipients with hepatic dysfunction. Clin Exp Immunol (1972) 1.06
Corneal endothelial permeability after anterior chamber silicone oil. Ophthalmology (1990) 1.05
The GARP gene encodes a new member of the family of leucine-rich repeat-containing proteins. Cell Growth Differ (1994) 1.05
Effects of adenosine diphosphate, colchicine and temperature on size of human platelets. Thromb Haemost (1979) 1.05
Chromosomal localization of the hst oncogene and its co-amplification with the int.2 oncogene in a human melanoma. Oncogene (1988) 1.04
Expression and signal transduction of the FLT3 tyrosine kinase receptor. Acta Haematol (1996) 1.04
ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines. Oncogene (2007) 1.04
Relation between bicarbonate concentration and rate of canine pancreatic secretion. Am J Physiol (1965) 1.03
Expression of human class I histocompatibility antigens at the surface of DNA-transformed mouse L cells. Immunogenetics (1982) 1.03
NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid leukemia. Leukemia (2007) 1.03
Hematopoietic receptors of class III receptor-type tyrosine kinases. Crit Rev Oncog (1993) 1.03
The role of the branched-chain amino acids in decreasing muscle catabolism in vivo. Surgery (1978) 1.02